Nureca Ltd's Q3FY25 Quarter Results
- 25 Jan 2025
Result Summary
- Nureca Ltd reported a 18.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a decline of 1.2%.
- Its expenses for the quarter were down by 9.4% QoQ and up 14.2% YoY.
- The net profit increased 483.3% QoQ and decreased 1850.0% YoY.
- The earnings per share (EPS) of Nureca Ltd declined at 2.8 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 27.94 | 34.36 | 28.28 | -18.7% | -1.2% |
Total Expenses | 31.20 | 34.44 | 27.33 | -9.4% | 14.2% |
Profit Before Tax | -3.25 | -0.08 | 0.94 | 3962.5% | -445.7% |
Tax | -0.45 | 0.41 | 0.78 | -209.8% | -157.7% |
Profit After Tax | -2.80 | -0.48 | 0.16 | 483.3% | -1850.0% |
Earnings Per Share | -2.80 | -0.50 | 0.20 | 460.0% | -1500.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Nureca Ltd is a company engaged in the manufacturing and distribution of healthcare and wellness products. The company operates in the healthcare industry, focusing on delivering a wide range of products aimed at health monitoring and improving the quality of life for its consumers. Nureca Ltd offers products such as blood pressure monitors, nebulizers, oxygen concentrators, and other medical devices that cater to both individual consumers and healthcare institutions. As of the latest information available up to October 2023, there have been no major developments or shifts in the company's strategic direction or product offerings reported.
Revenue
During the third quarter of fiscal year 2025 (Q3FY25), Nureca Ltd reported a total income of ₹27.94 crores. This represents a quarter-over-quarter (QoQ) decline of 18.7% compared to the second quarter of fiscal year 2025 (Q2FY25), where the total income was ₹34.36 crores. On a year-over-year (YoY) basis, there was a slight decrease of 1.2% from the ₹28.28 crores reported in the third quarter of fiscal year 2024 (Q3FY24). These figures indicate fluctuations in the company's revenue generation over the periods compared, with the most recent quarter showing a notable decrease in income.
Profitability
Nureca Ltd's profitability metrics for Q3FY25 reveal a challenging quarter. The company recorded a loss before tax of ₹3.25 crores, significantly widened from the ₹0.08 crores loss in Q2FY25 and a profit of ₹0.94 crores in Q3FY24. The QoQ change in profit before tax is a substantial increase in loss by 3962.5%, while the YoY change is a decline of 445.7%. The tax expense for Q3FY25 was negative ₹0.45 crores, contrasting with a positive tax of ₹0.41 crores in Q2FY25 and ₹0.78 crores in Q3FY24. Consequently, the profit after tax for Q3FY25 was a loss of ₹2.80 crores, compared to a loss of ₹0.48 crores in Q2FY25 and a profit of ₹0.16 crores in Q3FY24. The earnings per share (EPS) followed a similar trajectory, recording a value of -₹2.80 in Q3FY25, down from -₹0.50 in Q2FY25 and ₹0.20 in Q3FY24.
Operating Metrics
The financial data indicates that Nureca Ltd experienced an increase in total expenses to ₹31.20 crores in Q3FY25, down from ₹34.44 crores in Q2FY25, but up from ₹27.33 crores in Q3FY24. The QoQ change in total expenses was a decrease of 9.4%, while the YoY change was an increase of 14.2%. These figures suggest that while the company managed to reduce its expenses compared to the previous quarter, it still faced higher costs compared to the same quarter in the previous year. The changes in expenses, combined with declining revenues, have impacted the company's operating performance for the third quarter of fiscal year 2025.
